ANDRX (ADRX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ANDRX (ADRX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Emec who wrote (62)	4/21/1998 11:52:00 PM
From: PAUL ROBERT ST. ONGE	Read Replies (2) of 127

That certainly is a conservative number to say the least. Prilosec is growing at a annual clip of nearly 30%! If Andrx files for NDA Prilosec the new drug could hit the market in 1999, and you could then advance that revenue stream forward to next year. The analyst's would then have to revise up their estimates in a big way! This company landed the biggest ANDA of all time, and the stock trades down a 1/8th. People are stupid! This by all standards is huge news, and most investors barely blinked. While I understand that this is the future, a NDA version likely would hit the market much sooner. While no one can tell either way, in simple terms it certainly looks like that is the direction. I would expect Astra-Merck to likely cut a deal with Andrx if a NDA were to be filed. They would most certainly have too, or otherwise lose blockbuster sales. MRK could easily buy-out the company for plain stock, protect their drug. If MRK doubled the stock price of Andrx, it would still be a good deal for them. Regardless, Andrx continues to deliver and I expect in coming weeks we will be much higher than where we are now!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next